| appearance as argument number 1 |
|
| (documentation Roflumilast EnglishLanguage "Roflumilast, sold under the trade name Daxas among others, is a drug that acts as a selective, long-acting inhibitor of the enzyme phosphodiesterase-4 (PDE-4). It has anti-inflammatory effects and is used as an orally administered drug for the treatment of inflammatory conditions of the lungs such as chronic obstructive pulmonary disease (COPD) [from Wikipedia]") | Medicine.kif 3913-3918 | |
| (sideEffect Roflumilast Diarrhea) | Medicine.kif 3923-3923 | Diarrhea is a side effect of taking roflumilast |
| (sideEffect Roflumilast Headache) | Medicine.kif 3922-3922 | Headache is a side effect of taking roflumilast |
| (sideEffect Roflumilast Nausea) | Medicine.kif 3921-3921 | Nausea is a side effect of taking roflumilast |
| (subclass Roflumilast Antiinflammatory) | Medicine.kif 3912-3912 | Roflumilast is a subclass of Antiinflammatory |
| appearance as argument number 2 |
|
|
| (diseaseMedicine ChronicObstructivePulmonaryDisease Roflumilast Ingesting) | Medicine.kif 3920-3920 | COPD is disease treatment roflumilast for ingesting |
| (subclass Daxas Roflumilast) | Medicine.kif 3925-3925 | Daxas is a subclass of roflumilast |
| (termFormat EnglishLanguage Roflumilast "roflumilast") | Medicine.kif 3919-3919 | Daxas is a subclass of roflumilast |
|
Show full definition with tree view
Show simplified definition (without tree view)
Show simplified definition (with tree view)
|
|
Sigma web home Suggested Upper Merged Ontology (SUMO) web home
Sigma version 3.0 is open source software produced by Articulate Software and its partners